4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001179110-21-011225
EVP, Chief Scientific Officer acquired 9,084 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Shearman Mark S · EVP, Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-12-22 | Grant or award : show line 1 in the form | +9,084 | 41,785 | D |
Loading xslF345X03/edgar.xml…